Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
149.4 USD | -3.20% | +1.93% | -21.92% |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-21.92% | 18.82B | |
+9.30% | 46.03B | |
+52.73% | 44.55B | |
+7.15% | 40.8B | |
-8.78% | 28.25B | |
+18.68% | 27.71B | |
+14.62% | 13.91B | |
+31.85% | 12.43B | |
-8.77% | 11.06B | |
+4.47% | 10.81B |
- Stock
- Equities
- Stock Alnylam Pharmaceuticals, Inc. - Nasdaq
- News Alnylam Pharmaceuticals, Inc.
- Transcript : Alnylam Pharmaceuticals, Inc. Presents at Goldman Sachs 43rd Annual Global Healthcare Conference, Jun-13-2022 02